Penumbra Inc (NYSE: PEN), a global healthcare company focused on innovative therapies, announced on Tuesday that it has named Jason Mills as its new executive vice president, Strategy.

Prior to joining Penumbra, Mills had served Canaccord Genuity as managing director and head of the medical technology equity research practice over a long term.

Mills said, 'I am elated to join Penumbra, excited to immerse myself in its robust culture, and committed to help in every way possible to augment Penumbra's dedication to the development of innovative therapies. I am grateful for the opportunity to contribute to this amazing team and company and to Penumbra's mission to do work that matters to physicians, patients, and their families.'